| 57130-30-0 Basic information More.. |
Product Name: | 16,17-Dihydroapovincamine | Synonyms: | 16,17-Dihydroapovincamine;Vinpocetine Impurity 8;Vinpocetine Impurity 15 HCl;Vinpocetine-22;Eburnamenine-14-carboxylic acid, 14,15-dihydro-, methyl ester, (3α,16α);Eburnamenine-14-carboxylic acid, 14,15-dihydro-, methyl ester, (3α,16α)- (9CI) | CAS: | 57130-30-0 | MF: | C21H26N2O2 | MW: | 338.44 | EINECS: | | Mol File: | 57130-30-0.mol | |
|
57130-30-0
Recommend Suppliers |
Company Name: |
Beijing Comparison Pharmaceutical Technology Co., Ltd
Recommend
Complaint |
|
Tel: |
010-010-52878169 |
FAX: |
|
Email: |
sales@bjcomparison.com |
Products Intro: |
Product Name:methyl (41S,13aS)-13a-ethyl-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate hydrochloride CAS:57130-30-0 Purity:99.07% Package:100mg/;50mg/;25mg/;10mg/ Remarks:CCT064-23
More... |
CB Index: |
58 |
WebSite: |
www.bjcomparison.com |
Related Information: |
Sales Network
Catalog(4816)
User Evaluation(4)
|
Company Name: |
Wuxi Zhongkun Biochemical Technology Co., Ltd.
Recommend
Complaint |
|
Tel: |
0510-85629785 |
FAX: |
051085625359 |
Email: |
sales@reading-chemicals.com |
Products Intro: |
Product Name:methyl (41S,13aS)-13a-ethyl-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate hydrochloride CAS:57130-30-0 Purity:95%+ Package:根据客户需求包装
More... |
CB Index: |
58 |
WebSite: |
www.reading-chemicals.com |
Related Information: |
Sales Network
Catalog(15185)
User Evaluation(1)
|
Company Name: |
Anhui Feixiang Pharmaceutical Technology Co., Ltd.
Recommend
Complaint |
|
Tel: |
13349001619 |
FAX: |
|
Email: |
sales@feixiangpharm.com |
Products Intro: |
Product Name:methyl (41S,13aS)-13a-ethyl-2,3,41,5,6,12,13,13a-octahydro-1Hindolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylatehydrochloride CAS:57130-30-0 Purity:99% Package:10mg;25mg;50mg;100mg
More... |
CB Index: |
58 |
WebSite: |
www.feixiangpharm.com |
Related Information: |
Sales Network
Catalog(1008)
User Evaluation
|
|